Global Personalized Medicines In Oncology Industry Research Report 2021 Segmented by Major Market Players, Types, Applications and Countries Forecast to 2027
Date: Apr-2021 | Id: MACRC-62859 | Geographical Scope: Global | Publisher: Mnemonics Research
The global Personalized Medicines In Oncology market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2020 to 2027, based on Mnemonics Rresearch newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America). By Market Verdors: Biotheranostics Illumina DNA Link Genomic Health, Inc.(Exact Sciences) Cypher Genomics(Human Longevity, Inc.) Life Technologies Corporation(Thermo Fisher Scientific) Fulgent Genetics Caris Life Sciences Ariana Pharma Abbott Laboratories deCODE genetics Exagen Inc By Types: Molecular Oncopathology Genome Diagnostics Radiation Therapy Oncology Testing Chemotherapy Others By Applications: Research Centers Governmental Institutions Hospitals Clinical Centers Others Key Indicators Analysed Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors. Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications. Market Trends: Market key trends which include Increased Competition and Continuous Innovations. Opportunities and <b>Drivers:</b> Identifying the Growing Demands and New Technology Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry. Key Reasons to Purchase To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape. Assess the production processes, major issues, and solutions to mitigate the development risk. To understand the most affecting driving and restraining forces in the market and its impact in the global market. Learn about the market strategies that are being adopted by leading respective organizations. To understand the future outlook and prospects for the market. Besides the standard structure reports, we also provide custom research according to specific requirements.
1 Report Overview 1.1 Study Scope and Definition 1.2 Research Methodology 1.2.1 Methodology/Research Approach 1.2.2 Data Source 1.3 Key Market Segments 1.4 Players Covered: Ranking by Personalized Medicines In Oncology Revenue 1.5 Market Analysis by Type 1.5.1 Global Personalized Medicines In Oncology Market Size Growth Rate by Type: 2021 VS 2027 1.5.2 Molecular Oncopathology 1.5.3 Genome Diagnostics 1.5.4 Radiation Therapy 1.5.5 Oncology Testing 1.5.6 Chemotherapy 1.5.7 Others 1.6 Market by Application 1.6.1 Global Personalized Medicines In Oncology Market Share by Application: 2022-2027 1.6.2 Research Centers 1.6.3 Governmental Institutions 1.6.4 Hospitals 1.6.5 Clinical Centers 1.6.6 Others 1.7 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth 1.7.1 Covid-19 Impact: Global GDP Growth, 2019, 2021 and 2022 Projections 1.7.2 Covid-19 Impact: Commodity Prices Indices 1.7.3 Covid-19 Impact: Global Major Government Policy 1.8 Study Objectives 1.9 Years Considered 2 Global Personalized Medicines In Oncology Market Trends and Growth Strategy 2.1 Market Top Trends 2.2 Market Drivers 2.3 Market Challenges 2.4 Porter’s Five Forces Analysis 2.5 Market Growth Strategy 2.6 SWOT Analysis 3 Global Personalized Medicines In Oncology Market Players Profiles 3.1 Biotheranostics 3.1.1 Biotheranostics Company Profile 3.1.2 Biotheranostics Personalized Medicines In Oncology Product Specification 3.1.3 Biotheranostics Personalized Medicines In Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.2 Illumina 3.2.1 Illumina Company Profile 3.2.2 Illumina Personalized Medicines In Oncology Product Specification 3.2.3 Illumina Personalized Medicines In Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.3 DNA Link 3.3.1 DNA Link Company Profile 3.3.2 DNA Link Personalized Medicines In Oncology Product Specification 3.3.3 DNA Link Personalized Medicines In Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.4 Genomic Health, Inc.(Exact Sciences) 3.4.1 Genomic Health, Inc.(Exact Sciences) Company Profile 3.4.2 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Product Specification 3.4.3 Genomic Health, Inc.(Exact Sciences) Personalized Medicines In Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.5 Cypher Genomics(Human Longevity, Inc.) 3.5.1 Cypher Genomics(Human Longevity, Inc.) Company Profile 3.5.2 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Product Specification 3.5.3 Cypher Genomics(Human Longevity, Inc.) Personalized Medicines In Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.6 Life Technologies Corporation(Thermo Fisher Scientific) 3.6.1 Life Technologies Corporation(Thermo Fisher Scientific) Company Profile 3.6.2 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Product Specification 3.6.3 Life Technologies Corporation(Thermo Fisher Scientific) Personalized Medicines In Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.7 Fulgent Genetics 3.7.1 Fulgent Genetics Company Profile 3.7.2 Fulgent Genetics Personalized Medicines In Oncology Product Specification 3.7.3 Fulgent Genetics Personalized Medicines In Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.8 Caris Life Sciences 3.8.1 Caris Life Sciences Company Profile 3.8.2 Caris Life Sciences Personalized Medicines In Oncology Product Specification 3.8.3 Caris Life Sciences Personalized Medicines In Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.9 Ariana Pharma 3.9.1 Ariana Pharma Company Profile 3.9.2 Ariana Pharma Personalized Medicines In Oncology Product Specification 3.9.3 Ariana Pharma Personalized Medicines In Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.10 Abbott Laboratories 3.10.1 Abbott Laboratories Company Profile 3.10.2 Abbott Laboratories Personalized Medicines In Oncology Product Specification 3.10.3 Abbott Laboratories Personalized Medicines In Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.11 deCODE genetics 3.11.1 deCODE genetics Company Profile 3.11.2 deCODE genetics Personalized Medicines In Oncology Product Specification 3.11.3 deCODE genetics Personalized Medicines In Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021) 3.12 Exagen Inc 3.12.1 Exagen Inc Company Profile 3.12.2 Exagen Inc Personalized Medicines In Oncology Product Specification 3.12.3 Exagen Inc Personalized Medicines In Oncology Production Capacity, Revenue, Price and Gross Margin (2016-2021) 4 Global Personalized Medicines In Oncology Market Competition by Market Players 4.1 Global Personalized Medicines In Oncology Production Capacity Market Share by Market Players (2016-2021) 4.2 Global Personalized Medicines In Oncology Revenue Market Share by Market Players (2016-2021) 4.3 Global Personalized Medicines In Oncology Average Price by Market Players (2016-2021) 5 Global Personalized Medicines In Oncology Production by Regions (2016-2021) 5.1 North America 5.1.1 North America Personalized Medicines In Oncology Market Size (2016-2021) 5.1.2 Personalized Medicines In Oncology Key Players in North America (2016-2021) 5.1.3 North America Personalized Medicines In Oncology Market Size by Type (2016-2021) 5.1.4 North America Personalized Medicines In Oncology Market Size by Application (2016-2021) 5.2 East Asia 5.2.1 East Asia Personalized Medicines In Oncology Market Size (2016-2021) 5.2.2 Personalized Medicines In Oncology Key Players in East Asia (2016-2021) 5.2.3 East Asia Personalized Medicines In Oncology Market Size by Type (2016-2021) 5.2.4 East Asia Personalized Medicines In Oncology Market Size by Application (2016-2021) 5.3 Europe 5.3.1 Europe Personalized Medicines In Oncology Market Size (2016-2021) 5.3.2 Personalized Medicines In Oncology Key Players in Europe (2016-2021) 5.3.3 Europe Personalized Medicines In Oncology Market Size by Type (2016-2021) 5.3.4 Europe Personalized Medicines In Oncology Market Size by Application (2016-2021) 5.4 South Asia 5.4.1 South Asia Personalized Medicines In Oncology Market Size (2016-2021) 5.4.2 Personalized Medicines In Oncology Key Players in South Asia (2016-2021) 5.4.3 South Asia Personalized Medicines In Oncology Market Size by Type (2016-2021) 5.4.4 South Asia Personalized Medicines In Oncology Market Size by Application (2016-2021) 5.5 Southeast Asia 5.5.1 Southeast Asia Personalized Medicines In Oncology Market Size (2016-2021) 5.5.2 Personalized Medicines In Oncology Key Players in Southeast Asia (2016-2021) 5.5.3 Southeast Asia Personalized Medicines In Oncology Market Size by Type (2016-2021) 5.5.4 Southeast Asia Personalized Medicines In Oncology Market Size by Application (2016-2021) 5.6 Middle East 5.6.1 Middle East Personalized Medicines In Oncology Market Size (2016-2021) 5.6.2 Personalized Medicines In Oncology Key Players in Middle East (2016-2021) 5.6.3 Middle East Personalized Medicines In Oncology Market Size by Type (2016-2021) 5.6.4 Middle East Personalized Medicines In Oncology Market Size by Application (2016-2021) 5.7 Africa 5.7.1 Africa Personalized Medicines In Oncology Market Size (2016-2021) 5.7.2 Personalized Medicines In Oncology Key Players in Africa (2016-2021) 5.7.3 Africa Personalized Medicines In Oncology Market Size by Type (2016-2021) 5.7.4 Africa Personalized Medicines In Oncology Market Size by Application (2016-2021) 5.8 Oceania 5.8.1 Oceania Personalized Medicines In Oncology Market Size (2016-2021) 5.8.2 Personalized Medicines In Oncology Key Players in Oceania (2016-2021) 5.8.3 Oceania Personalized Medicines In Oncology Market Size by Type (2016-2021) 5.8.4 Oceania Personalized Medicines In Oncology Market Size by Application (2016-2021) 5.9 South America 5.9.1 South America Personalized Medicines In Oncology Market Size (2016-2021) 5.9.2 Personalized Medicines In Oncology Key Players in South America (2016-2021) 5.9.3 South America Personalized Medicines In Oncology Market Size by Type (2016-2021) 5.9.4 South America Personalized Medicines In Oncology Market Size by Application (2016-2021) 5.10 Rest of the World 5.10.1 Rest of the World Personalized Medicines In Oncology Market Size (2016-2021) 5.10.2 Personalized Medicines In Oncology Key Players in Rest of the World (2016-2021) 5.10.3 Rest of the World Personalized Medicines In Oncology Market Size by Type (2016-2021) 5.10.4 Rest of the World Personalized Medicines In Oncology Market Size by Application (2016-2021) 6 Global Personalized Medicines In Oncology Consumption by Region (2016-2021) 6.1 North America 6.1.1 North America Personalized Medicines In Oncology Consumption by Countries 6.1.2 United States 6.1.3 Canada 6.1.4 Mexico 6.2 East Asia 6.2.1 East Asia Personalized Medicines In Oncology Consumption by Countries 6.2.2 China 6.2.3 Japan 6.2.4 South Korea 6.3 Europe 6.3.1 Europe Personalized Medicines In Oncology Consumption by Countries 6.3.2 Germany 6.3.3 United Kingdom 6.3.4 France 6.3.5 Italy 6.3.6 Russia 6.3.7 Spain 6.3.8 Netherlands 6.3.9 Switzerland 6.3.10 Poland 6.4 South Asia 6.4.1 South Asia Personalized Medicines In Oncology Consumption by Countries 6.4.2 India 6.5 Southeast Asia 6.5.1 Southeast Asia Personalized Medicines In Oncology Consumption by Countries 6.5.2 Indonesia 6.5.3 Thailand 6.5.4 Singapore 6.5.5 Malaysia 6.5.6 Philippines 6.6 Middle East 6.6.1 Middle East Personalized Medicines In Oncology Consumption by Countries 6.6.2 Turkey 6.6.3 Saudi Arabia 6.6.4 Iran 6.6.5 United Arab Emirates 6.7 Africa 6.7.1 Africa Personalized Medicines In Oncology Consumption by Countries 6.7.2 Nigeria 6.7.3 South Africa 6.8 Oceania 6.8.1 Oceania Personalized Medicines In Oncology Consumption by Countries 6.8.2 Australia 6.9 South America 6.9.1 South America Personalized Medicines In Oncology Consumption by Countries 6.9.2 Brazil 6.9.3 Argentina 6.10 Rest of the World 6.10.1 Rest of the World Personalized Medicines In Oncology Consumption by Countries 7 Global Personalized Medicines In Oncology Production Forecast by Regions (2022-2027) 7.1 Global Forecasted Production of Personalized Medicines In Oncology (2022-2027) 7.2 Global Forecasted Revenue of Personalized Medicines In Oncology (2022-2027) 7.3 Global Forecasted Price of Personalized Medicines In Oncology (2022-2027) 7.4 Global Forecasted Production of Personalized Medicines In Oncology by Region (2022-2027) 7.4.1 North America Personalized Medicines In Oncology Production, Revenue Forecast (2022-2027) 7.4.2 East Asia Personalized Medicines In Oncology Production, Revenue Forecast (2022-2027) 7.4.3 Europe Personalized Medicines In Oncology Production, Revenue Forecast (2022-2027) 7.4.4 South Asia Personalized Medicines In Oncology Production, Revenue Forecast (2022-2027) 7.4.5 Southeast Asia Personalized Medicines In Oncology Production, Revenue Forecast (2022-2027) 7.4.6 Middle East Personalized Medicines In Oncology Production, Revenue Forecast (2022-2027) 7.4.7 Africa Personalized Medicines In Oncology Production, Revenue Forecast (2022-2027) 7.4.8 Oceania Personalized Medicines In Oncology Production, Revenue Forecast (2022-2027) 7.4.9 South America Personalized Medicines In Oncology Production, Revenue Forecast (2022-2027) 7.4.10 Rest of the World Personalized Medicines In Oncology Production, Revenue Forecast (2022-2027) 7.5 Forecast by Type and by Application (2022-2027) 7.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2022-2027) 7.5.2 Global Forecasted Consumption of Personalized Medicines In Oncology by Application (2022-2027) 8 Global Personalized Medicines In Oncology Consumption Forecast by Regions (2022-2027) 8.1 North America Forecasted Consumption of Personalized Medicines In Oncology by Country 8.2 East Asia Market Forecasted Consumption of Personalized Medicines In Oncology by Country 8.3 Europe Market Forecasted Consumption of Personalized Medicines In Oncology by Countriy 8.4 South Asia Forecasted Consumption of Personalized Medicines In Oncology by Country 8.5 Southeast Asia Forecasted Consumption of Personalized Medicines In Oncology by Country 8.6 Middle East Forecasted Consumption of Personalized Medicines In Oncology by Country 8.7 Africa Forecasted Consumption of Personalized Medicines In Oncology by Country 8.8 Oceania Forecasted Consumption of Personalized Medicines In Oncology by Country 8.9 South America Forecasted Consumption of Personalized Medicines In Oncology by Country 8.10 Rest of the world Forecasted Consumption of Personalized Medicines In Oncology by Country 9 Global Personalized Medicines In Oncology Sales by Type (2016-2027) 9.1 Global Personalized Medicines In Oncology Historic Market Size by Type (2016-2021) 9.2 Global Personalized Medicines In Oncology Forecasted Market Size by Type (2022-2027) 10 Global Personalized Medicines In Oncology Consumption by Application (2016-2027) 10.1 Global Personalized Medicines In Oncology Historic Market Size by Application (2016-2021) 10.2 Global Personalized Medicines In Oncology Forecasted Market Size by Application (2022-2027) 11 Global Personalized Medicines In Oncology Manufacturing Cost Analysis 11.1 Personalized Medicines In Oncology Key Raw Materials Analysis 11.1.1 Key Raw Materials 11.2 Proportion of Manufacturing Cost Structure 11.3 Manufacturing Process Analysis of Personalized Medicines In Oncology 12 Global Personalized Medicines In Oncology Marketing Channel, Distributors, Customers and Supply Chain 12.1 Marketing Channel 12.2 Personalized Medicines In Oncology Distributors List 12.3 Personalized Medicines In Oncology Customers 12.4 Personalized Medicines In Oncology Supply Chain Analysis 13 Analyst's Viewpoints/Conclusions 14 Disclaimer
Related reports
Pharmaceutical Grade Sodium Chloride Market
$2850-$4575
Adenosine Triphosphate ATP Test Kit Market
$3300-$7000
Alpha 1 Antitrypsin Deficiency Treatment Market
$3300-$7000